Navigation Links
Caliper Life Sciences Announces Preliminary Results for the Fourth Quarter and 2010
Date:1/13/2011

y," commented Kevin Hrusovsky, President and CEO.  "Other recent highlights include surpassing 1,000 cumulative IVIS imaging systems sold, acquiring tissue analysis capabilities via our acquisition of CRi and entering the rapidly expanding molecular diagnostics market through the recent launch of the LabChip® Dx and a content partnership with Seegene, a leader in multiplexed diagnostic reagents.  Today, we are pleased to announce we received our first order from Seegene for 17 Labchip Dx systems valued at over $500,000 to be shipped over the next three months to customers in six countries," added Hrusovsky.

2011 Revenue Guidance For 2011, the Company currently expects total revenue to increase between 12- 20% overall, in comparison to non-GAAP revenues of approximately $120 million for fiscal 2010.  See table below for reconciliation.  

Statement Regarding Use of Non-GAAP Financial MeasuresCaliper supplements its GAAP financial reporting with certain non-GAAP financial measures.  The non-GAAP organic revenue growth percentage in this press release excludes the impact of revenue from business operations which were divested in the second quarter of 2010.  Caliper believes that providing this additional information enhances investors' understanding of the financial performance of Caliper's operations and increases the comparability of its current financial statements to prior periods.  Non-GAAP earnings per share as referred to in this press release refers to GAAP earnings per share, adjusted to exclude amortization expense related to intangible assets, non-cash restructuring charges and credits, and non-recurring acquisition-related charges.

Presentation at Today's J.P. Morgan ConferenceAs announced in a separate press release issued by the company on January 5, 2011, Caliper will today make a presentation at the J.P. Morgan Healthcare Conference in San Francisco, California.  A live webcast of
'/>"/>

SOURCE Caliper Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Caliper Life Sciences CEO to Present Keynote Presentation at MipTec European Conference
2. Caliper Life Sciences to Present at UBS 2010 Global Life Sciences Conference
3. Caliper Life Sciences Second Quarter 2010 Financial Results Conference Call Notice
4. Caliper Owners Group Meeting Showcases Critical Role of Biopharma and Academic Researchers for Improving Healthcare and Quality of Life
5. Caliper Life Sciences to Webcast Investor Session of Open House
6. Caliper Life Sciences to Present at Jefferies 2010 Global Life Sciences Conference
7. Caliper Enhances Strategic Focus and Increases Growth Capital with Sale of Product Lines to Biotage
8. Caliper Awarded Additional Task Order for EPA ToxCast Program
9. Caliper Life Sciences to Present at Deutsche Banks 35th Annual Health Care Conference
10. Caliper Life Sciences Launches LabChip(R) XT for Next Generation Sequencing Applications
11. Caliper Life Sciences Launches Living Image(R) 4.0 Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Florida (PRWEB) , ... September 02, 2015 , ... ... been treated and managed with the use of special anti-vascular endothelial growth factor ... in many more patients, currently does not have a scientific protocol for the ...
(Date:9/2/2015)... 02, 2015 Research ... addition of Jain PharmaBiotech,s new report "Biomarkers ... offering. This report follows the broad ... can be objectively measured and evaluated as an ... well as pharmacological responses to a therapeutic intervention. ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/cqsxmg/gene_therapy ... report "Gene Therapy - Technologies, Markets and Companies" ... gene therapy are difficult to estimate as there is ... marketed in China since 2004. ... The estimates are based on epidemiology of diseases to ...
(Date:9/2/2015)... 2015 Research ... the addition of Jain PharmaBiotech,s new report ... to their offering. The ... fluorescence in situ hybridization (FISH), comparative genomic ... includes application of nanobiotechnology, microarrays, real-time polymerase ...
Breaking Biology Technology:StemCell GeneticMed Announces That It Has Started Stem Cell Treatments for Age Related Dry Macular Degeneration (AMG) 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Global Gene Therapy Market Study 2015-2024 - Technologies, Markets and Companies Analysis 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 3
... - AEterna Zentaris Inc.,(NASDAQ: AEZS ; TSX: ... and oncology, today reported the completion of patient,recruitment ... Phase 3 program,in benign prostatic hyperplasia (BPH), a ... candidate, cetrorelix. The study,involves approximately 600 patients primarily ...
... FRESNO, Calif., April 15 Chairman & CEO, Paul ... agribusiness company, Dr.,Mark E. Whitacre has risen fast at ... operating officer and president of operations.",Now Cypress and Whitacre ... in order to get Americans -- and people around ...
... Clinical Trials ... Session -, SAN ... today announced that data from an ongoing,Phase 1-2 clinical trial showed that ... prostate specific,antigen (PSA), a marker of tumor growth, in the lowest expanded ...
Cached Biology Technology:AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia 3AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia 4Cypress Systems, Inc. Launches Cancer Prevention Health Campaign Using SelenoExcell(R) 2Cypress Systems, Inc. Launches Cancer Prevention Health Campaign Using SelenoExcell(R) 3Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients 2Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients 3
(Date:8/12/2015)... JOSE, Calif. , Aug. 12, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that ... recently announced Match-in-Sensor solution, have officially been named ... Alliance. As part of the certification, Synaptics, Natural ... FIDO 1.0 Universal Authentication Framework (UAF) standard and ...
(Date:8/10/2015)... Germany , August 10, 2015 ... leader in Eye Tracking Technology for more than two ... Tracking Platform for integration into all consumer display formats. ... for seamless integration of eye tracking into consumer tablets, ... augmented reality smart glasses. Omnivision,s leading sensor technology contributes ...
(Date:8/6/2015)... Aug. 6, 2015  Today, U.S. Congressman ... Crossmatch ™ to learn firsthand how Silicon Valley ... Crossmatch is a world leader in multi-factor identity ... are helping federal agencies and commercial organizations achieve ... "The vast majority of network breaches ...
Breaking Biology News(10 mins):Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Rep. Honda to Visit Crossmatch in Redwood City 2
... common condition that causes frequent nighttime trips to ... treatment that shrinks the prostate, suggests a study being ... Scientific Meeting in New Orleans. The early findings hail ... embolization (PAE), which reduces blood flow to the prostate, ...
... The largest genetic search for "obesity genes" in people of ... regions of the human genome that influence obesity in these ... Health and Information Sciences Department of Epidemiology and Population Health ... 2013), published their findings in Nature Genetics . ...
... a system of genes that bacteria use to defend themselves ... some bacteria evade the mammalian immune system. The results ... . CRISPR is itself a sort of immune system ... seeking to prevent phages, the viruses that infect bacteria, from ...
Cached Biology News:Nonsurgical treatment turns back the clock, shrinks enlarged prostate 2Genetic discovery found to influence obesity in people of African ancestry 2Bacterial security agents go rogue 2Bacterial security agents go rogue 3
... sets a new standard for high performance ... new design in instrumentation, this easy-to-use benchtop ... The BD FACSAria instrument is the first ... flow cell. This new flow cell ...
Mouse monoclonal antibody raised against a partial recombinant COG2. NCBI Entrez Gene ID = COG2...
Mouse polyclonal antibody raised against a partial recombinant IFNA13. NCBI Entrez Gene ID = 3447...
Mouse monoclonal antibody raised against a full length recombinant LDB3. NCBI Entrez Gene ID = LDB3...
Biology Products: